News

Regulatory affairsRegulatory Round-up - January 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Spliceor receives investment from the Cell and Gene Therapy Catapult as part of the Cross-Catapult Investment PilotSpliceor receives investment from the Cell and Gene Therapy Catapult as part of the Cross-Catapult Investment PilotCGT Catapult response to publication of the Life Sciences Sector PlanCGT Catapult response to publication of the Life Sciences Sector PlanCellular Origins, Cell and Gene Therapy Catapult and Resolution Therapeutics form consortium to deliver fully automated robotics CGT manufacturing platformCellular Origins, Cell and Gene Therapy Catapult and Resolution Therapeutics form consortium to deliver fully automated robotics CGT manufacturing platformRegulatory Round-up - June 2025Regulatory Round-up - June 2025From nascent to mainstream: Overcoming barriers in iPSC therapy developmentFrom nascent to mainstream: Overcoming barriers in iPSC therapy developmentScience Minister Lord Vallance opens Digital and Automation Testbeds that will improve advanced therapies manufacturingScience Minister Lord Vallance opens Digital and Automation Testbeds that will improve advanced therapies manufacturingRegulatory Round-up - May 2025Regulatory Round-up - May 2025The digital revolution in cell and gene therapy: Insights from Advanced Therapies Integrates NorthThe digital revolution in cell and gene therapy: Insights from Advanced Therapies Integrates NorthCGT Catapult and Nakanoshima Qross to foster stronger relationships between the advanced therapies industry in the UK and JapanCGT Catapult and Nakanoshima Qross to foster stronger relationships between the advanced therapies industry in the UK and JapanChallenge Theme R&D spotlight: CGT Catapult HEK cell line developed to optimise rAAV vector productionChallenge Theme R&D spotlight: CGT Catapult HEK cell line developed to optimise rAAV vector productionRegulatory Round-up - April 2025Regulatory Round-up - April 2025INmune Bio partners with Cell and Gene Therapy Catapult to scale up CORDStrom™ manufacturing for commercial readinessINmune Bio partners with Cell and Gene Therapy Catapult to scale up CORDStrom™ manufacturing for commercial readiness